Actualización del año 2018 de las guías AHA/ACC de manejo del colesterol, validada por múltiples sociedades tales como AACVPR, AAPA, ABC, ACPM, ADA, AGS, APhA, ASPC, NLA y PCNA. All rights reserved. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/ APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. The following are key perspectives from the 2018 multisociety Guideline on the Management of Blood Cholesterol, based on the Top Ten Take Home Messages selected by the Writing Committee. Download File. Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Interventions and Imaging, Computed Tomography, Nuclear Imaging, Diet, Exercise, Keywords: Atherosclerosis, Body Weight Changes, Cardiac Imaging Techniques, Cholesterol, Cost-Benefit Analysis, Costs and Cost Analysis, Decision Making, Diabetes Mellitus, Diet, Dyslipidemias, Exercise, HIV Infections, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Inflammation, Multidetector Computed Tomography, Life Style, Lipids, Lipoproteins, Mass Screening, Metabolic Syndrome X, Motor Activity, Patient Compliance, Pediatrics, Plaque, Atherosclerotic, Primary Prevention, Renal Insufficiency, Chronic, Risk Assessment, Risk Factors, Risk Reduction Behavior, Safety, Secondary Prevention, Value of Life, Vascular Diseases, Women. Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Pulmonary Hypertension and Venous Thromboembolism, CardioSource Plus for Institutions and Practices, Nuclear Cardiology and Cardiac CT Meeting on Demand, Annual Scientific Session and Related Events, ACC Quality Improvement for Institutions Program, National Cardiovascular Data Registry (NCDR). An accompanying review of risk assessment tools to guide decision making for prevention of ASCVD is very helpful (see Lloyd-Jones DM, et al., Special Report on Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of ASCVD. In patients 40 to 75 years of age with diabetes mellitus and an LDL-C level of ≥70 mg/dl, start moderate-intensity statins without calculating 10-year ASCVD risk. Description: Guidelines Made Simple | 2018 Blood Cholesterol Guideline Date: November 10, 2018 J Am Coll Cardiol 2018;Nov 10:[Epub ahead of print]. Año: 2018; URL: 2018 AHA/ACC Guideline on the Management of Blood Cholesterol; Categoría: Sección Prevención /Riesgo Cardiovascular © 2020 American College of Cardiology Foundation. The following are key perspectives from the 2018 multisociety Guideline on the Management of Blood Cholesterol, based on the Top Ten Take Home Messages selected by the Writing Committee. © 2020 American College of Cardiology Foundation. Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Pulmonary Hypertension and Venous Thromboembolism, CardioSource Plus for Institutions and Practices, Nuclear Cardiology and Cardiac CT Meeting on Demand, Annual Scientific Session and Related Events, ACC Quality Improvement for Institutions Program, National Cardiovascular Data Registry (NCDR), Congenital Heart Disease and     Pediatric Cardiology, Invasive Cardiovascular Angiography    and Intervention, Pulmonary Hypertension and Venous     Thromboembolism. The 2018 guideline emphasizes reducing risk of atherosclerotic cardiovascular disease (ASCVD) through lipid management. Invasive Cardiovascular Angiography and Intervention, Use of Risk Assessment Tools to Guide Decision-Making in ASCVD Prevention, New AHA/ACC Cholesterol Guideline Allows For More Personalized Care; New Treatment Options, Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk, IMProved Reduction of Outcomes: Vytorin Efficacy International Trial, Congenital Heart Disease and     Pediatric Cardiology, Invasive Cardiovascular Angiography    and Intervention, Pulmonary Hypertension and Venous     Thromboembolism. It updates the 2013 guideline and emphasizes a more intensive approach based on recent controlled studies and expert consensus. The following resource contains tables and figures from the 2018 Guideline for the Management of Blood Cholesterol. All rights reserved. Description: Guidelines Made Simple | 2018 Blood Cholesterol Guideline. The 2018 Cholesterol Guideline is a full revision of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterolto Reduce Atherosclerotic Cardiovascular Risk in Adults. I have taken the liberty to utilize the 10 important points selected by the Writing Committee and make comments (italicized) based on other content and my clinical practice and experience. In patients with diabetes mellitus at higher risk, especially those with multiple risk factors or those 50 to 75 years of age, it is reasonable to use a high-intensity statin to reduce the LDL-C level by ≥50%. J Am Coll Cardiol 2018;Nov 10:[Epub ahead of print]). The 2018 guideline emphasizes reducing risk of atherosclerotic cardiovascular disease (ASCVD) through lipid management.